(Q40526809)

21 September 2017

1 reference

title

Antibiotic formulary selection (English)

1 reference

21 September 2017

Crowe HM

1

1 reference

21 September 2017

Quintiliani R

series ordinal

2

1 reference

21 September 2017

publication date

1 May 1995

1 reference

Medical Clinics of North America

21 September 2017

published in

1 reference

21 September 2017

volume

79

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

463-476

1 reference

Consequences of intravascular catheter sepsis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Comparison of gentamicin dosing regimens using an in-vitro model.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Twelve-hourly dosage schedule for oral and intravenous metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Strategic antibiotic decision-making at the formulary level

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930050-5

7 January 2021

10.1016/S0025-7125(16)30050-5

Identifiers

DOI

0 references

1 reference